Mylan Pharmaceuticals ULC, the Canadian unit of Mylan Inc. (MYL: Quote) said Thursday that it received approval from Health Canada for Mylan-Rosuvastatin Calcium Tablets, 5mg, 10mg, 20mg and 40mg.
According to IMS Health, sales of Rosuvastatin Calcium Tablets in Canada was about C$742 million for the year ended Dec. 31, 2011.
Mylan-Rosuvastatin is the generic version of Astra Zeneca Plc's (AZN) Crestor Tablets. The drug is used for the management of primary hypercholesterolaemia, mixed dyslipidaemia, and familial hypercholesterolaemia.
Click here to receive FREE breaking news email alerts for Mylan Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com